Recent Advances in the Pharmacotherapy of Premature Ejaculation
Abstract
Premature ejaculation (PE) can be a very distressing condition and has been studied for many years. However, there exists confusion about the definition, incidence, and management of this condition. Treatment through pharmacotherapy has been focussed on topical agents along with oral antidepressant medications. The use of sexual psychology can also play a role in treatment of PE, often when added to medical therapies. Other alternative medical treatments have also been used with mixed outcomes. Although there is no perfect treatment for PE that works for every patient every time, there is ongoing research for the optimal therapy for men who complain about this problem. A review of the current understanding and medical management of PE will be set in this paper along with potential future treatments.
Read the paper
Related studies
- Validation of Three Early Ejaculation Diagnostic Tools: A Composite Measure Is Accurate and More Adequate for Diagnosis by Updated Diagnostic Criteria
- Functional insights into aberrant brain responses and integration in patients with lifelong premature ejaculation
- Anatomic Basis and Clinical Effect of Selective Dorsal Neurectomy for Patients with Lifelong Premature Ejaculation: A Randomized Controlled Trial
- Classification and definition of premature ejaculation
- Drug Repurposing Approaches to Combating Viral Infections
- The antidepressant Sertraline inhibits CatSper Ca2+ channels in human sperm
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.